Old Web
English
Sign In
Acemap
>
authorDetail
>
Takehiro Aoki
Takehiro Aoki
Eli Lilly and Company
Medicine
Rheumatology
Internal medicine
Psoriasis
Generalized pustular psoriasis
3
Papers
260
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J)
2017
Journal of Dermatology
Hidehisa Saeki
Hidemi Nakagawa
Ko Nakajo
Taeko Ishii
Yoji Morisaki
Takehiro Aoki
Gregory S. Cameron
Olawale Osuntokun
Show All
Source
Cite
Save
Citations (94)
Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
2016
The Journal of Rheumatology
Yoshiya Tanaka
K. Emoto
Zhihong Cai
Takehiro Aoki
D. Schlichting
Terence Rooney
William L. Macias
Show All
Source
Cite
Save
Citations (90)
Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis.
2015
Journal of The European Academy of Dermatology and Venereology
Hidehisa Saeki
Hidemi Nakagawa
T. Ishii
Y. Morisaki
Takehiro Aoki
P.-Y. Berclaz
Michael P. Heffernan
Show All
Source
Cite
Save
Citations (76)
1